Importantly, miR-377-3p has been identified as a novel inhibitor of CPT1C, capable of targeting the expression of CPT1C to reduce the rate of fatty acid β-oxidation, thereby inhibiting the growth and metastasis of HCC (129). The gene discussed is CPT1C; the disease is hepatocellular carcinoma.